Pediatrics

February 9th 2023

Eylea now also treats retinopathy of prematurity, a leading cause of childhood blindness worldwide.

January 5th 2023

Nirsevimab is a single-dose, long-acting antibody to protect infants from respiratory syncytial virus (RSV) lower respiratory tract infections. The FDA action date is in the third quarter of 2023.

January 4th 2023

Wegovy is a once-weekly prescription medication for obesity that has faced supply issues. Its manufacturer, Novo Nordisk, is increasing production capacity in 2023.

December 17th 2022

If approved, Linzess would be the first prescription therapy for functional constipation in children and adolescents 6 to 17 years of age.